Literature DB >> 25623565

[A meta-analysis of the prevalence and risk factors of irritable bowel syndrome in Chinese community].

Lu Zhang, Liping Duan1, Yixuan Liu, Yuxin Leng, Hua Zhang, Zuojing Liu, Kun Wang.   

Abstract

OBJECTIVE: To estimate the prevalence and risk factors for irritable bowel syndrome (IBS) in China.
METHODS: Cross-sectional studies relevant to IBS conducted among Chinese were identified through the databases including PubMed, Web of Science, the Cochrane Library, CBM, CNKI, Wanfang data and VIP. Quality of studies was assessed according to the criteria for cross-sectional studies recommended by Agency for Healthcare Research and Quality (AHRQ). Analysis of data, publication bias and sensitivity were performed with Stata (Version 12.0).
RESULTS: A total of twenty-three studies were extracted. No obvious publication bias was detected in all analysis except the effect of depression on IBS prevalence. Pooled prevalence of IBS in China was 6.5%. IBS was more common in women than in men (8.1% vs 6.8%;OR = 1.23, 95%CI 1.09-1.38) and high rate in age group between 30 to 59 years (6.9%; OR = 1.22, 95%CI 1.12-1.32) . Intestinal infection history (OR = 2.39, 95%CI 1.69-3.38), anxiety (OR = 2.95, 95%CI 1.94-4.49), depression (OR = 1.85, 95%CI 1.11-3.09), food allergy (OR = 2.80, 95%CI 2.12-3.67) and alcohol consumption (OR = 1.15, 95%CI 1.07-1.24) might increase the risk for IBS. There were no significant difference of IBS prevalence between urban and rural areas (OR = 0.97, 95%CI 0.72-1.29) , neither in different education classes (OR = 0.85, 95%CI 0.70-1.03) . Sub-group analysis showed IBS prevalence varied apparently with different diagnostic criteria: prevalence defined by Manning was 11.8% and by RomeIIand Rome III prevalence values were 4.4% and 8.9% respectively.
CONCLUSIONS: Pooled prevalence of IBS in China was 6.5%. IBS is more common in age group between 30 to 59 years. Female, history of intestinal infection, anxiety, depression, food allergy and alcohol consumption were risk factors for IBS in Chinese population.

Entities:  

Mesh:

Year:  2014        PMID: 25623565

Source DB:  PubMed          Journal:  Zhonghua Nei Ke Za Zhi        ISSN: 0578-1426


  10 in total

1.  Mechanisms of Probiotic VSL#3 in a Rat Model of Visceral Hypersensitivity Involves the Mast Cell-PAR2-TRPV1 Pathway.

Authors:  Ying-Jie Li; Cong Dai; Min Jiang
Journal:  Dig Dis Sci       Date:  2018-12-17       Impact factor: 3.199

Review 2.  Mind-Body Interventions for Irritable Bowel Syndrome Patients in the Chinese Population: a Systematic Review and Meta-Analysis.

Authors:  Weidong Wang; Fang Wang; Feng Fan; Ana Cristina Sedas; Jian Wang
Journal:  Int J Behav Med       Date:  2017-04

3.  The Prevalence of Irritable Bowel Syndrome Among Chinese University Students: A Systematic Review and Meta-Analysis.

Authors:  Weixin Yang; Xiao Yang; Xianghao Cai; Zhuoren Zhou; Huan Yao; Xingrong Song; Tianyun Zhao; Peng Xiong
Journal:  Front Public Health       Date:  2022-04-15

4.  Golden bifid might improve diarrhea-predominant irritable bowel syndrome via microbiota modulation.

Authors:  Mei Luo; Qin Liu; Lin Xiao; Li-Shou Xiong
Journal:  J Health Popul Nutr       Date:  2022-05-16       Impact factor: 2.966

Review 5.  Nerve growth factor and diarrhea-predominant irritable bowel syndrome (IBS-D): a potential therapeutic target?

Authors:  Xiao-juan Xu; Liang Liu; Shu-kun Yao
Journal:  J Zhejiang Univ Sci B       Date:  2016-01       Impact factor: 3.066

6.  Predictors of healthcare-seeking behavior among Chinese patients with irritable bowel syndrome.

Authors:  Wen-Juan Fan; Dong Xu; Min Chang; Li-Ming Zhu; Gui-Jun Fei; Xiao-Qing Li; Xiu-Cai Fang
Journal:  World J Gastroenterol       Date:  2017-11-14       Impact factor: 5.742

7.  Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome.

Authors:  Wei Wei; Hui-Fen Wang; Yu Zhang; Yan-Li Zhang; Bing-Yu Niu; Shu-Kun Yao
Journal:  World J Gastroenterol       Date:  2020-12-07       Impact factor: 5.742

8.  To assess the effective and safety of compound glutamine entersoluble capsules in irritable bowel syndrome: A protocol for systematic review and meta-analysis.

Authors:  Yong Zhang; Ru Liu; Jin Wang; Shuguang Yan; Zhiqing Guo
Journal:  Medicine (Baltimore)       Date:  2021-03-12       Impact factor: 1.817

9.  Efficacy and indication optimization of Chinese medicine (Tiao-Chang Ke-Min granules) for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized controlled trial.

Authors:  Qian Li; Bei-Ping Zhang; Shao-Gang Huang; Wen-Wei Ouyang; Jian-Hui Xie; Ze-Huai Wen; Xiao-Bo Yang
Journal:  Trials       Date:  2018-07-11       Impact factor: 2.279

10.  Antidiarrheal activity of methanol extract of Sophora tonkinensis in mice and spasmolytic effect on smooth muscle contraction of isolated jejunum in rabbits.

Authors:  Yangyou Li; Jing Li; Xin Liu; Jianwu Zhang; Xue Mei; Rudan Zheng; Wei Chen; Qian Zheng; Shangjie Zhong
Journal:  Pharm Biol       Date:  2019-12       Impact factor: 3.503

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.